Geopolitics Alpha

8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Lexeo Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
  • Exposed: LXEO, XLV, AMGN, GILD, MRNA
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Lexeo Therapeutics, Inc.(0001907108) (Filer)LXEOGEOPOLITICS ALPHA

8-K - Lexeo Therapeutics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).

Directly affected

  • LXEO Lexeo Therapeutics

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Lexeo Therapeutics belongs to, so it often moves with news about it.

  • AMGN Amgen+15.9% 30d

    Amgen is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

  • GILD Gilead Sciences+16.4% 30d

    Gilead Sciences is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

  • MRNA Moderna+22.4% 30d

    Moderna is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

  • ARGX argenx SE-11.9% 9d

    argenx SE is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

  • RVMD Revolution Medicines

    Revolution Medicines is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
LXEO+9.76%+7.14%baseafter closeafter closeafter closeafter close
XLV-0.28%+0.04%baseafter closeafter closeafter closeafter close
AMGN-0.08%+0.56%baseafter closeafter closeafter closeafter close
GILD+0.80%+0.98%baseafter closeafter closeafter closeafter close
MRNA+20.51%+11.41%baseafter closeafter closeafter closeafter close
ARGX+0.34%+1.85%baseafter closeafter closeafter closeafter close
RVMD+16.24%+4.86%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-16 AccNo: 0001193125-26-462015 Size: 28 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

Lexeo Therapeutics (LXEO) since “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” compared with the market

CompanyWhenMoveStatus
Amgen (AMGN)three days earlier+0.56%final price
Amgen (AMGN)five days earlier-0.08%final price
Argenx Se (ARGX)three days earlier+1.85%final price
Argenx Se (ARGX)five days earlier+0.34%final price
Gilead Sciences (GILD)three days earlier+0.98%final price
Gilead Sciences (GILD)five days earlier+0.80%final price
Lexeo Therapeutics (LXEO)three days earlier+7.14%final price
Lexeo Therapeutics (LXEO)five days earlier+9.76%final price
Moderna (MRNA)three days earlier+11.41%final price
Moderna (MRNA)five days earlier+20.51%final price
Revolution Medicines (RVMD)three days earlier+4.86%final price
Revolution Medicines (RVMD)five days earlier+16.24%final price
Select Sector Spdr Tr (XLV)three days earlier+0.04%final price
Select Sector Spdr Tr (XLV)five days earlier-0.28%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Lexeo Therapeutics (LXEO)

Companies carried with this story

  • LXEO Lexeo Therapeutics

    For “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Lexeo Therapeutics (LXEO) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> LXEO

  • XLV Select Sector Spdr Tr

    For “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR holds the health sector that Lexeo Therapeutics belongs to, so it often moves with news about it

  • AMGN Amgen

    For “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Amgen (AMGN) is linked, with no stored direction, medium confidence. Reason on file: Amgen is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news

  • GILD Gilead Sciences

    Gilead Sciences (GILD) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer).” Reason on file: Gilead Sciences is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news

  • MRNA Moderna

    In “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Moderna (MRNA) is linked, with no stored direction, medium confidence. Reason on file: Moderna is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news

  • ARGX Argenx Se

    Argenx Se (ARGX) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer).” Reason on file: argenx SE is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news

  • RVMD Revolution Medicines

    In “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer),” Revolution Medicines (RVMD) is linked, with no stored direction, medium confidence. Reason on file: Revolution Medicines is a peer of Lexeo Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news

How “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer)” reaches Lexeo Therapeutics (LXEO)

The 16 Nov 2026 story “8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer)” names Lexeo Therapeutics (LXEO) because of this story.

For Lexeo Therapeutics (LXEO), the reason on file says SEC 8-K filing -> direct issuer disclosure -> LXEO

Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Lexeo Therapeutics belongs to, so it often moves with news about it

The price range for Lexeo Therapeutics (LXEO), and the dates in the story

AMGN traded between 424.75 and 482.71 across 20 sessions. The latest close on file is 466.99.

How strong the case is around Lexeo Therapeutics (LXEO)

46 out of 100

“8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.